AI Article Synopsis

  • Pain management in cirrhosis patients is complex, with 62% receiving opioids during hospitalization and 34% using them regularly, which is higher than in non-cirrhosis patients.
  • Opioid use patterns vary, with cirrhosis patients more likely to receive tramadol and less likely to use opioid/acetaminophen combos.
  • Serious adverse events related to opioids occur at similar rates for both patient groups, indicating the need for further research on opioid safety and efficacy in cirrhosis.

Article Abstract

Pain is common among patients with cirrhosis, yet managing pain in this population is challenging. Opioid analgesics are thought to be particularly high risk in patients with cirrhosis, and their use has been discouraged. We sought to understand patterns of opioid use among inpatients with cirrhosis and the risks of serious opioid-related adverse events in this population. We used the Vizient Clinical Database/Resource Manager, which includes clinical and billing data from hospitalizations at more than 500 academic medical centers. We identified all nonsurgical patients with cirrhosis hospitalized in 2017-2018 as well as a propensity score-matched cohort of patients without cirrhosis. Inpatient prescription records defined patterns of inpatient opioid use. Conditional logistic regression compared rates of use and serious opioid-related adverse events between patients with and without cirrhosis. Of 116,146 nonsurgical inpatients with cirrhosis, 62% received at least one dose of opioids and 34% had regular inpatient opioid use (more than half of hospital days), rates that were significantly higher than in patients without cirrhosis (adjusted odds ratio [AOR] for any use, 1.17; 95% confidence interval [CI], 1.13-1.21;  < 0.001; AOR for regular use, 1.07; 95% CI, 1.02-1.11;  = 0.002). Compared with patients without cirrhosis, patients with cirrhosis more often received tramadol ( < 0.001) and less commonly received opioid/acetaminophen combinations ( < 0.001). Rates of serious opioid-related adverse events were similar in patients with and without cirrhosis (1.6% vs. 1.9%; AOR, 0.96;  = 0.63). Over half of patients with cirrhosis have pain managed with opioids during hospitalization. Patterns of opioid use differ in patients with cirrhosis compared with patients without cirrhosis, although rates of serious adverse events are similar. Future studies should further explore the safety and efficacy of opioids in patients with cirrhosis, with the goal of improving pain management and quality of life in this population.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183179PMC
http://dx.doi.org/10.1002/hep4.1694DOI Listing

Publication Analysis

Top Keywords

patients cirrhosis
28
inpatient opioid
12
adverse events
12
cirrhosis
9
patterns inpatient
8
events patients
8
inpatients cirrhosis
8
serious opioid-related
8
opioid-related adverse
8
patients
7

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!